UK markets closed

Atossa Therapeutics, Inc. (ATOS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.0100-0.0800 (-7.34%)
At close: 04:00PM EDT
1.0400 +0.03 (+2.97%)
After hours: 07:56PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 145.62M
Enterprise value 5.58M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.08
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.26

Trading information

Stock price history

Beta (5Y monthly) 1.99
52-week change 3-82.25%
S&P500 52-week change 3-11.93%
52-week high 37.1500
52-week low 30.8400
50-day moving average 31.0228
200-day moving average 31.7162

Share statistics

Avg vol (3-month) 31.82M
Avg vol (10-day) 32.94M
Shares outstanding 5126.62M
Implied shares outstanding 6N/A
Float 8118.83M
% held by insiders 10.04%
% held by institutions 135.00%
Shares short (14 Jun 2022) 416.04M
Short ratio (14 Jun 2022) 411.46
Short % of float (14 Jun 2022) 412.67%
Short % of shares outstanding (14 Jun 2022) 412.67%
Shares short (prior month 12 May 2022) 417.14M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 319 Apr 2018
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 319 Apr 2018

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-9.75%
Return on equity (ttm)-15.90%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -21.72M
Net income avi to common (ttm)-21.85M
Diluted EPS (ttm)-0.1740
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)131.49M
Total cash per share (mrq)1.04
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)58.94
Book value per share (mrq)1.06

Cash flow statement

Operating cash flow (ttm)-16.94M
Levered free cash flow (ttm)-8.11M